Innova Captab Limited (INNOVACAP.NS)
INR 1016.6
(0.7%)
INR 1016.6
(0.7%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.45 Billion INR | -43.36% |
| 2022 | 4.32 Billion INR | 117.29% |
| 2021 | 1.99 Billion INR | 337.76% |
| 2020 | 454.97 Million INR | 0.0% |
| 2019 | - INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 5.17 Billion INR | 16.58% |
| 2023 FY | 2.45 Billion INR | -43.36% |
| 2023 Q4 | 2.45 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | 4.43 Billion INR | 2.54% |
| 2022 Q4 | 4.32 Billion INR | 0.0% |
| 2022 FY | 4.32 Billion INR | 117.29% |
| 2021 FY | 1.99 Billion INR | 337.76% |
| 2020 FY | 454.97 Million INR | 0.0% |
| 2019 FY | - INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 1.43 Billion INR | -71.339% |
| Ind-Swift Limited | 10.13 Billion INR | 75.828% |
| Bajaj HealthCare Limited | 3.32 Billion INR | 26.356% |
| Sakar Healthcare Limited | 793.51 Million INR | -208.884% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 96.313% |
| Divi's Laboratories Limited | 30 Million INR | -8070.133% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -5230.434% |
| Morepen Laboratories Limited | 289.99 Million INR | -745.21% |
| Mankind Pharma Limited | 2.07 Billion INR | -18.309% |
| Sequent Scientific Limited | 4.87 Billion INR | 49.742% |
| Wanbury Limited | 1.16 Billion INR | -110.418% |
| Laurus Labs Limited | 25.77 Billion INR | 90.49% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 61.434% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -1329.345% |
| Alembic Limited | 91.5 Million INR | -2578.732% |
| Hikal Limited | 8.17 Billion INR | 70.021% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 52.236% |
| Neuland Laboratories Limited | 953.89 Million INR | -156.95% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 35.099% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 80.088% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -648.181% |
| Themis Medicare Limited | 957.92 Million INR | -155.871% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 69.522% |
| Lupin Limited | 29.21 Billion INR | 91.611% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -14081.797% |
| Wockhardt Limited | 23.56 Billion INR | 89.597% |
| Vaishali Pharma Limited | 134.91 Million INR | -1716.689% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | 14.074% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -2641.349% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 93.31% |
| FDC Limited | 205.18 Million INR | -1094.551% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 87.757% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -674.506% |
| Eris Lifesciences Limited | 27.81 Billion INR | 91.187% |
| Venus Remedies Limited | 413.3 Million INR | -493.041% |
| ZIM Laboratories Limited | 1.08 Billion INR | -125.229% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -145.497% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 19.7 Million INR | -12341.827% |
| Shilpa Medicare Limited | 9.37 Billion INR | 73.852% |
| Albert David Limited | 33.24 Million INR | -7273.323% |
| Ajanta Pharma Limited | 352.8 Million INR | -594.739% |
| Hester Biosciences Limited | 2.44 Billion INR | -0.297% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -277.104% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 75.768% |
| Gufic Biosciences Limited | 3.32 Billion INR | 26.377% |
| Windlas Biotech Limited | 36.41 Million INR | -6631.777% |
| Procter & Gamble Health Limited | 95.6 Million INR | -2463.849% |
| Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | -681.773% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -148.855% |
| Granules India Limited | 13.15 Billion INR | 81.362% |
| Aarti Drugs Limited | 5.64 Billion INR | 56.563% |
| Bal Pharma Limited | 1.39 Billion INR | -75.515% |
| Alkem Laboratories Limited | 14.18 Billion INR | 82.72% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 92.513% |
| Lincoln Pharmaceuticals Limited | 10.66 Million INR | -22875.628% |
| Medicamen Biotech Limited | 308.17 Million INR | -695.348% |
| Unichem Laboratories Limited | 2.47 Billion INR | 0.974% |
| Bafna Pharmaceuticals Limited | 243.89 Million INR | -904.965% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -55745.067% |
| Valiant Laboratories Limited | 767.08 Million INR | -219.527% |
| Orchid Pharma Limited | 1.35 Billion INR | -81.316% |
| Medico Remedies Limited | 80.5 Million INR | -2944.619% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -1374.611% |
| Ipca Laboratories Limited | 14.38 Billion INR | 82.959% |
| Brooks Laboratories Limited | 56.41 Million INR | -4244.352% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -238.137% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.543% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 93.906% |
| NATCO Pharma Limited | 3.71 Billion INR | 33.97% |
| Suven Life Sciences Limited | 7.09 Million INR | -34436.283% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -26.715% |
| Strides Pharma Science Limited | 25.16 Billion INR | 90.262% |
| Indoco Remedies Limited | 6.71 Billion INR | 63.524% |
| Alpa Laboratories Limited | 52.46 Million INR | -4571.762% |
| Lasa Supergenerics Limited | 220.76 Million INR | -1010.264% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -300.824% |